Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times ...

DelveInsight's GnRH Receptor Antagonists Market Size, Target Population, Competitive Landscape & Market Forecast report ...

Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Europe's pharmaceutical companies are bracing for United States President Donald Trump's plan to slap tariffs of up to 250 ...

Treatment Devices Market is set to grow at a CAGR of 6.35% from 2025 to 2032. This surge is driven by rising COPD prevalence due to factors like tobacco smoking and air pollution, increased awareness, ...

Genmab Announces Financial Results for the First Half of 2025August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025HighlightsEpcoritamab advancing to earlier lines ...

In Q2 2025, the global pharma sector experienced a decline in M&A activity, with deals worth $32.9 billion, down 11.6% from Q1. Deal volume fell 12.8% to 130. Oncology led with 51 deals. Discover key ...

DelveInsight's CLK Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive unders ...

The Trump administration has imposed a tariff of 39 percent on Swiss goods — drastically higher than the rates for the EU or ...